Natera, Inc.
NTRA
DELAYED 1 MONTH
38 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 16 1:05 AM | Jonathan SheenaDirector, Other | Sale | 1,500 | $201.56 | $302.3K | 19,532(I) | View → |
| May 8, 2026 | May 16 1:05 AM | Jonathan SheenaDirector, Other | Sale | 3,150 | $208.60 | $657.1K | 252,502(D) | View → |
| May 5, 2026 | May 7 1:35 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 6,986 | $213.77 | $1.5M | 2,377,843(D) | View → |
| May 4, 2026 | May 7 1:35 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 722 | $206.16 | $148.8K | 2,382,440(D) | View → |
| May 4, 2026 | May 6 1:45 AM | Michael Burkes BrophyCHIEF FINANCIAL OFFICER | Sale | 482 | $210.49 | $101.5K | 57,496(D) | View → |
| May 1, 2026 | May 6 1:45 AM | Michael Burkes BrophyCHIEF FINANCIAL OFFICER | Sale | 313 | $206.16 | $64.5K | 57,978(D) | View → |
| May 1, 2026 | May 6 1:35 AM | Jonathan SheenaDirector, Other | Sale | 107 | $206.16 | $22.1K | 255,652(D) | View → |
| May 1, 2026 | May 6 1:35 AM | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | Sale | 3,405 | $203.69 | $693.6K | 142,295(D) | View → |
| May 1, 2026 | May 6 1:35 AM | John FeskoPRESIDENT, CHIEF BUS. OFFICER | Sale | 291 | $206.16 | $60.0K | 187,220(D) | View → |
| May 1, 2026 | May 6 1:35 AM | Steven Leonard ChapmanDirector, CEO AND PRESIDENT | Sale | 902 | $206.16 | $186.0K | 149,867(D) | View → |
| May 1, 2026 | May 6 1:35 AM | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | Sale | 330 | $206.16 | $68.0K | 222,694(D) | View → |
| Mar 13, 2026 | Mar 18 1:05 AM | Rowan E ChapmanDirector | Sale | 122 | $191.38 | $23.3K | 5,752(D) | View → |
| Mar 16, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 50,000 | $196.28 | $9.8M | 2,310,772(D) | View → |
| Mar 13, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 75,000 | $189.01 | $14.2M | 2,310,772(D) | View → |
| Mar 12, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 75,000 | $190.59 | $14.3M | 2,310,772(D) | View → |
| Mar 10, 2026 | Mar 12 1:35 AM | Michael Burkes BrophyCHIEF FINANCIAL OFFICER | Sale | 785 | $204.13 | $160.2K | 63,354(D) | View → |
| Mar 10, 2026 | Mar 12 1:35 AM | Steven Leonard ChapmanDirector, CEO AND PRESIDENT | Sale | 5,623 | $204.13 | $1.1M | 156,607(D) | View → |
| Mar 10, 2026 | Mar 12 1:05 AM | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | Sale | 1,745 | $204.13 | $356.2K | 233,285(D) | View → |
| Mar 10, 2026 | Mar 12 1:05 AM | Jonathan SheenaDirector, Other | Sale | 127 | $204.13 | $25.9K | 262,325(D) | View → |
| Mar 10, 2026 | Mar 12 1:05 AM | John FeskoPRESIDENT, CHIEF BUS. OFFICER | Sale | 707 | $204.13 | $144.3K | 189,199(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 10 1:05 AM | Gail Boxer MarcusDirector | Option Exercise | 11,000 | $22.83 | 11,000(D) | View → |
| Mar 16, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Option Exercise | 50,000 | $9.59 | 100,000(D) | View → |
| Mar 13, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Option Exercise | 75,000 | $9.59 | 150,000(D) | View → |
| Mar 12, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Option Exercise | 75,000 | $9.59 | 225,000(D) | View → |
| Mar 6, 2026 | Mar 11 1:05 AM | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | Option Exercise | 5,598 | $19.68 | 0(D) | View → |
| Mar 2, 2026 | Mar 4 2:05 AM | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | Option Exercise | 5,125 | $9.59 | 0(D) | View → |